eXoZymes Inc
EXOZ12.300USD
+0.100+0.82%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
103.16MMarket Cap
LossP/E TTM
More Details of eXoZymes Inc Company
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
eXoZymes Inc Info
Ticker SymbolEXOZ
Company nameeXoZymes Inc
IPO dateNov 13, 2024
CEOHeltzen (Michael)
Number of employees31
Security typeOrdinary Share
Fiscal year-endNov 13
Address750 Royal Oaks Dr
CityMONROVIA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91016
Phone16264151488
Websitehttps://exozymes.com/
Ticker SymbolEXOZ
IPO dateNov 13, 2024
CEOHeltzen (Michael)
Company Executives of eXoZymes Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
646.48K
-3.94%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
16.58K
+6.69%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
6.98K
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Director
Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
646.48K
-3.94%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
16.58K
+6.69%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
6.98K
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Aug 23
Updated: Sat, Aug 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
MDB Capital Holdings, LLC
46.87%
Korman (Tyler Ph.D.)
8.68%
Opgenorth (Paul Hideo)
7.71%
Bowie (James U. Ph.D.)
6.89%
Rayo (Edgardo Javier)
0.93%
Other
28.92%
Shareholders
Shareholders
Proportion
MDB Capital Holdings, LLC
46.87%
Korman (Tyler Ph.D.)
8.68%
Opgenorth (Paul Hideo)
7.71%
Bowie (James U. Ph.D.)
6.89%
Rayo (Edgardo Javier)
0.93%
Other
28.92%
Shareholder Types
Shareholders
Proportion
Corporation
46.87%
Individual Investor
24.86%
Investment Advisor
0.44%
Investment Advisor/Hedge Fund
0.28%
Other
27.55%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
11
75.38K
0.94%
--
2025Q3
11
75.38K
0.94%
--
2025Q2
11
75.38K
0.94%
-1.39K
2025Q1
9
76.77K
1.17%
-21.33K
2024Q4
7
98.10K
0.00%
+98.10K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
MDB Capital Holdings, LLC
3.93M
46.87%
--
--
Jun 09, 2025
Korman (Tyler Ph.D.)
728.28K
8.68%
-28.65K
-3.78%
Jun 16, 2025
Opgenorth (Paul Hideo)
646.48K
7.71%
-26.48K
-3.94%
Jun 13, 2025
Bowie (James U. Ph.D.)
577.91K
6.89%
--
--
Jun 09, 2025
Rayo (Edgardo Javier)
77.91K
0.93%
--
--
Jun 09, 2025
The Vanguard Group, Inc.
23.15K
0.28%
-27.22K
-54.03%
Jun 30, 2025
Geode Capital Management, L.L.C.
20.60K
0.25%
+3.00
+0.01%
Jun 30, 2025
Lalonde (James Joseph)
18.87K
0.23%
-174.00
-0.91%
Jun 09, 2025
Heltzen (Michael)
16.58K
0.2%
+1.04K
+6.69%
Jul 02, 2025
Bell (Lon E)
12.12K
0.14%
+12.12K
--
Jun 09, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of eXoZymes Inc?
The top five shareholders of eXoZymes Inc are:
MDB Capital Holdings, LLC holds 3.93M shares, accounting for 46.87% of the total shares.
Korman (Tyler Ph.D.) holds 728.28K shares, accounting for 8.68% of the total shares.
Opgenorth (Paul Hideo) holds 646.48K shares, accounting for 7.71% of the total shares.
Bowie (James U. Ph.D.) holds 577.91K shares, accounting for 6.89% of the total shares.
Rayo (Edgardo Javier) holds 77.91K shares, accounting for 0.93% of the total shares.
MDB Capital Holdings, LLC holds 3.93M shares, accounting for 46.87% of the total shares.
Korman (Tyler Ph.D.) holds 728.28K shares, accounting for 8.68% of the total shares.
Opgenorth (Paul Hideo) holds 646.48K shares, accounting for 7.71% of the total shares.
Bowie (James U. Ph.D.) holds 577.91K shares, accounting for 6.89% of the total shares.
Rayo (Edgardo Javier) holds 77.91K shares, accounting for 0.93% of the total shares.
What are the top three shareholder types of eXoZymes Inc?
The top three shareholder types of eXoZymes Inc are:
MDB Capital Holdings, LLC
Korman (Tyler Ph.D.)
Opgenorth (Paul Hideo)
MDB Capital Holdings, LLC
Korman (Tyler Ph.D.)
Opgenorth (Paul Hideo)
How many institutions hold shares of eXoZymes Inc (EXOZ)?
As of 2025Q4, 11 institutions hold shares of eXoZymes Inc, with a combined market value of approximately 75.38K, accounting for 0.94% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for eXoZymes Inc?
In --, the -- business generated the highest revenue for eXoZymes Inc, amounting to -- and accounting for --% of total revenue.
